

“Everything For Rapid Regeneration”

We develop groundbreaking medical devices in orthopedics and emergency response for conditions that affect millions of women and men worldwide.

The GSK Biomaterials product portfolio consists of new generation medical devices in two different areas. Our products in the R&D phase are waiting to benefit humanity.


Deep and bleeding injuries:
If not treated, often result in the death of patients due to blood loss. The first step in first aid for these injuries is to try to stop the bleeding. Deep and bleeding injuries are experienced especially in armed conflicts that frequently occur in the military and police teams’ interventions.
Bone regeneration & osteomyelitis :
Osteomyelitis is a bone infection that occurs when pathogens from nearby infected tissue or an open wound reach the bone, settle and multiply. If not prevented, it may require surgical intervention and may progress to amputation.
We support the healing of people in more than

AgBone
AgBone is a bone graft that contains antimicrobial agents in its structure, is suitable for direct use, and consists of completely biodegradable materials that will shorten the operation time and regeneration time.
- REDUCES the use of extra antibiotics after the intervention
- ACTS on bacterial and fungal pathogens during use
- Since it is not a kit like competing products, it SHORTENS the operation time
- Composite graft structure ACCELERATES bone regeneration by 25%
- Since the antimicrobial effect is provided by the material in a single product, it is more ECONOMICAL than grafts containing antibiotics


CELLULOSTAT
CELLULOSTAT, a rapid blood-stopping tampon, is applied to the bleeding area in deep and open injuries and stops bleeding quickly with the fibrin, bacterial cellulose and antimicrobial agent in its structure.
- REDUCES the use of extra antibiotics after the intervention
- ACTS on bacterial and fungal pathogens during use
- SHORTENS the bleeding time since it contains fibrin in its structure compared to competitor products
- Since it is derived from bacterial cellulose, its blood absorption feature is MORE compared to competitors
- Production cost is quite low compared to competitor products, therefore it is more ECONOMICAL





Our Team

Özgün Selim GERMİYAN
Founder (CEO)

Prof. Yiğit UYANIKGİL

Hazal ÇETİNER
Chief of Quality Assurance (CE & FDA Approval)

Yunus Emre ÖZ
Chief Technology Officer (CTO)